Cost of dementia: impact of disease progression estimated in longitudinal data

Abstract

Aims: Several studies have shown that health care costs are higher for demented than for non-demented persons and that health care costs are higher for more severe demented persons than less severe demented persons. However, most studies report on cross-sectional study designs, and thus fail to examine the influence of disease progression on changes in health care costs to individual persons. The objective of this study was, using longitudinal data, to examine changes in total health care costs with disease progression in demented persons. Methods: We assumed that disease progression could be characterised by transitions between different states of dementia which reflected the degree to which the disease progressed over time. Then, changes in health care costs were regressed on a set of explanatory variables including disease progression. A total of 465 demented and non-demented persons were interviewed twice. The time between interviews was about three years. Before each interview, the participant was examined for dementia and classified by type of dementia (Alzheimer's disease, vascular or other types of dementia) and degree of dementia (very mild, mild, moderate, severe). Results: The results of this longitudinal study confirmed that health care costs increased over time for non-demented as well as for demented persons and that health care costs increased with disease progression. In particular, the health care costs increased when the disease had progressed into the severe state of the dementia. Also, decline in functional abilities was an important factor for explaining changes in health care costs.

Keywords

Health economics dementia disease progression activities of daily living costs of dementia multivariate regression analysis.

Get full access to this article

View all access options for this article.

References

Fratiglioni L. Classification and diagnostics. In Wimo A , Jönsson B , Karlsson G , Winblad B (eds): Health economics of dementia. Wiley: Chichester, 1998: 3 - 12.

stbye T. , Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J 1994; 151: 1457-1464.

Ernst RL , Hay JW Economic research on Alzheimer's disease: A review of the literature . Alzheimer Dis Assoc Disord 1997; 11: 135 - 145.

Souêtre EJ , Qing W. , Vigoureux I. , Dartigues JhyphenF , Lozet H. , Lacomblez L. , erouesné C. Economic analysis of Alzheimer's disease in outpatients: Impact of symptom severity. Int Psychogeriatr 1995; 7: 115 - 122.

Andersen CK , Søgaard J. , Hansen E. , Kragh-Sørensen A. , Hastrup L. , Andersen J. , Andersen K. , Lolk A. , Nielsen H. , Kragh-Sørensen P. The cost of dementia in Denmark: The Odense study. Dement Geriatr Cogn Disord 1999; 10: 295 - 304.

Drummond MF , O'Brien BJ , Stoddart GL , Torrance GW Methods for the economic evaluation of health care programms. Oxford University Press: Oxford, 1997.

Andersen CK , Andersen K. , Kragh-Sørensen P. Cost function estimation: The choice of a model to apply to dementia . Health Econ 2000; 9: 397 - 409.

Andersen K. , Lolk A. , Nielsen H. , Andersen J. , Olsen C. , Kragh-Sørensen P. Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand 1997; 96: 82-87.

Andersen K. , Nielsen H. , Lolk A. , Andersen J. , Becker I. , Kragh-Sørensen P. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark. The Odense Study. Neurology 1999 ; 52: 85 - 90.

10.

McKhann G. , Drachman D. , Folstein MF , Katzman R. , Price D. , Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984 ; 34: 939 - 944.

11.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 1987 . Washington DC, American Psychiatric Association.

12.

Berg L. Clinical Dementia Rating (CDR). Psychopharmacology Bulletin 1988; 24: 637-639.

13.

Morris JC The Clinical Dementia Rating (CDR): Current version and scoring rules . Neurology 1993; 43: 2412 - 2414.

14.

Morris JC Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9: 173 - 176.

15.

Dranove D. Measuring costs. In Sloan F (eds): Valuing health care. Cambridge University Press: Cambridge, 1996: 61 - 75.

16.

Brorsson B. , Åsberg KH Katz index of independence in ADL . Scand J Rehabil Med 1984; 16: 125-132.

17.

Gaist D. , Sørensen HT , Hallas J. The Danish prescription registreis. Dan Med Bull 1997; 44: 445-448.

18.

Kristensen MB , Friis H. , Rassing MR Lægemiddelkataloget 1999: Med beskrivelse af samtlige registrerede farmaceutiske specialiteter til human brug, der sælges på de danske apoteker [The Danish Drug Catalogue] . Dansk Lægemiddel Information A/S: København, 1999.

19.

Wooldridge JM Introductory Econometrics: A Modern Approach . South-Western College: United Kingdom, 2000.

20.

Green WH Econometric analysis. Prentice Hall: Englewood Cliffs, 1993.

21.

Manning WG , Newhouse JP , Ware JE The status of health in demand estimation; or, beyond excelent, good, fair, and poos. In Fuchs VR (eds): Economic aspects of health. The University of Chicago Press : Chicago and London, 1982: 143-184.

22.

McNamee P. , Gregson BA , Wright K. , Buck D. , Bamford CH , Bond J. Estimation of a multiproduct cost function for physically frail older people . Health Econ 1998; 7: 301 - 310.